by Eric Distad, Senior Director, Medical Device & Diagnostics, Novella Clinical In a December 2015 blog post, I quoted a report by Technavio stating that bioresorbable coronary stents would be a key technology to watch over the next five years. Those in clinical development are either made of lactic acid polymers or use magnesium-based scaffolds, […]
The combination product development 3-step: Considerations for clinical trials
by Eric Distad, Senior Director, Medical Device & Diagnostics, Novella Clinical The market for drug device combination products is expected to grow at a compound annual growth rate of 11.95 percent by 2019, according to a new report from Technavio. The report, which segments the market by the following product types: drug-eluting stents, prefilled syringes, […]
DJO Global’s executive vice president resigns | Personnel Moves
Medical device maker DJO Global, Inc. announced that its executive vice president of U.S. commercial operations, Andrew Holman, will leave the company “to pursue other opportunities.”
Newly minted DJO president & CEO Mike Mogul will assume responsibility for the San Diego, Calif.-based company’s U.S. commercial activities.
Bupp steps down as Neoprobe CEO | Personnel moves
Neoprobe Corp. (NYSE Amex:NEOP) is getting a new chief executive and, perhaps, a new board member.
The Dublin, Ohio-based cancer diagnostics firm announced that CEO David Bupp will be replaced by chief development officer Mark Pykett on April 15.
